Skip to main content
Premium Trial:

Request an Annual Quote

Italy's Menarini Acquires Cell Array Firm Silicon Biosystems

NEW YORK (GenomeWeb News) – Italian pharmaceutical and diagnostics firm the Menarini Group has acquired Bologna-based Silicon Biosystems for an undisclosed sum, the firms announced today.

Silicon Biosystems has commercialized a microelectronic array-based platform, called DEPArray, that can isolate and manipulate cells, including rare cells such as stem cells and circulating tumor cells, in a suspension matrix.

Lucia Aleotti, chairman of the Menarini Group, said that the acquisition of Silicon Biosystems adds an "innovative high-tech company" to its existing programs in oncology.

As part of the Menarini Group, Silicon Biosystems will continue to operate as a standalone entity, the firms said, but will also have access to the "support and resources needed" to develop its technology and expand into clinical markets.

Founded in 1999, Silicon Biosystems expanded to the US in 2010 when it opened a subsidiary in San Diego. The company has since announced partnerships with Fox Chase Cancer Center, Baylor College of Medicine, and PGXL Technologies.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.